Immunomodulation and Development of Immunotherapies for Human Autoimmunity, Inflammation, Infection, Allergy, and Cancer
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Immunology and Immunotherapy".
Deadline for manuscript submissions: closed (30 June 2023) | Viewed by 1370
Special Issue Editors
Interests: immunology; immunology in type 1 diabetes; host-parasite interaction; immunomodulation by parasite; autoimmunity and inflammation; T cell biology
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
In mammals, the immune system protects the host by responding to attacks from a broad range of pathogens such as bacteria, parasites, and viruses while avoiding misguided or irrational immune reactions that are deleterious to the host. Both protective and detrimental immune responses are primarily facilitated by T and B cells, which possess enormous diversity in antigen recognition, high antigen specificity, potent effector activity, and long-lasting immunologic memory. Because of this potency, serious damage to the host may ensue if aberrant immune responses, such as autoimmunity or allergy, are triggered. A major challenge in immunology and biomedicine is to determine how the unresponsiveness of the adaptive immune system to self-antigens is established and maintained, and how the quality and magnitude of adaptive immune responses to non-self-antigens are controlled to avoid damage to the host. Despite technological advances, treatments for many and inflammatory and autoimmune diseases, including type 1 diabetes and rheumatoid arthritis, primarily rely on broad-spectrum immunosuppressive agents. However, the associated immunosuppressive regimens result in severe side effects, and safer and more effective treatments are thus required. Hence, increasing efforts have focused on developing immunotherapies aimed at targeting the underlying disease process to modulate the immune system, maximize critical cell function, and induce and/or enhance T-reg cells and their function.
Dr. Nitin P. Amdare
Dr. Phaneendra K. Duddempudi
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- immunomodulation
- immunotherapies
- immune system
- human autoimmunity
- inflammation
- infection
- allergy
- cancer
